Differential effects of arsenic on calcium signaling in primary keratinocytes and malignant (HSC-1) cells

Cell Calcium

Volumn 52, Issue 2, 2012, Pages 161-169

  Hsu, W L ^a   Tsai, M H ^a   Lin, M W ^b   Chiu, Y C ^a   Lu, J H ^a   Chang, C H ^b   Yu, H S ^b   Yoshioka, T ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Caged IP3; Calcium imaging; Keratinocytes (KCs); Store operated calcium (SOC) channel

Indexed keywords

ARSENIC; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEIN KINASE B; WORTMANNIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

EID: 84863613649     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2012.05.007     Document Type: Article

References (40)

1. Druwe I.L., Vaillancourt R.R. Influence of arsenate and arsenite on signal transduction pathways: an update. Archives of Toxicology 2010, 84:585-596.
2. Kapaj S., Peterson H., Liber K., Bhattacharya P. Human health effects from chronic arsenic poisoning-a review. Journal of Environmental Science and Health Part A: Toxic/Hazardous Substances & Environmental Engineering 2006, 41:2399-2428.
3. Yu H.S., Liao W.T., Chai C.Y. Arsenic carcinogenesis in the skin. Journal of Biomedical Science 2006, 13:657-666.
4. Liao W.T., Lan C.C., Lee C.H., Yu H.S. Concentration-dependent cellular responses of arsenic in keratinocytes. Kaohsiung Journal of Medical Sciences 2011, 27:390-395.
5. 2+ release and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2427-2432.
6. Rong Y., Distelhorst C.W. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annual Review of Physiology 2008, 70:73-91.
7. Soghoian D., Jayaraman V., Silane M., Berenstein A., Jayaraman T. Inositol 1,4,5-trisphosphate receptor phosphorylation in breast cancer. Tumour Biology 2005, 26:207-212.
8. Berridge M.J. Inositol trisphosphate and calcium signalling mechanisms. Biochimica et Biophysica Acta 2009, 1793:933-940.
9. Decuypere J.P., Monaco G., Missiaen L., De Smedt H., Parys J.B., Bultynck G. IP(3) receptors, mitochondria, and Ca signaling: implications for aging. Journal of Aging Research 2011, 2011:920178.
10. Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., Ojcius D.M. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. Journal of Biological Chemistry 2007, 282:2871-2879.
11. Kadenbach B., Arnold S., Lee I., Huttemann M. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochimica et Biophysica Acta 2004, 1655:400-408.
12. Capiod T., Shuba Y., Skryma R., Prevarskaya N. Calcium signalling and cancer cell growth. Sub-Cellular Biochemistry 2007, 45:405-427.
13. Liu L.Z., Jiang Y., Carpenter R.L., Jing Y., Peiper S.C., Jiang B.H. Role and mechanism of arsenic in regulating angiogenesis. PLoS One 2011, 6:e20858.
14. Pi J., He Y., Bortner C., et al. Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. International Journal of Cancer 2005, 116:20-26.
15. Lan C.C., Wu C.S., Huang S.M., et al. High-glucose environment inhibits p38MAPK signaling and reduces human beta-3 expression in keratinocytes. Molecular Medicine 2011, 17:771-779.
16. Zohar O., Ikeda M., Shinagawa H., et al. Thermal imaging of receptor-activated heat production in single cells. Biophysical Journal 1998, 74:82-89.
17. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicology and Applied Pharmacology 2007, 220:292-301.
18. Wang S.S., Augustine G.J. Confocal imaging and local photolysis of caged compounds: dual probes of synaptic function. Neuron 1995, 15:755-760.
19. 2+ release by cAMP-dependent protein kinase in a living cell. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:1613-1617.
20. Hsu W.L., Chung P.J., Tsai M.H., Chang C.L., Liang C.L. A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential. Virus Research 2012, 163:617-627.
21. Lee W.K., Choi S.W., Lee H.R., Lee E.J., Lee K.H., Kim H.O. Purinoceptor-mediated calcium mobilization and proliferation in HaCaT keratinocytes. Journal of Dermatological Science 2001, 25:97-105.
22. Inoue K., Hosoi J., Denda M. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. Journal of Investigative Dermatology 2007, 127:362-371.
23. Burnstock G. Purine and pyrimidine receptors. Cellular and Molecular Life Sciences 2007, 64:1471-1483.
24. Erb L., Liao Z., Seye C.I., Weisman G.A. P2 receptors: intracellular signaling. Pflugers Arch 2006, 452:552-562.
25. Schwiebert E.M., Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochimica et Biophysica Acta 2003, 1615:7-32.
26. Lambrecht G., Braun K., Damer M., et al. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists. Current Pharmaceutical Design 2002, 8:2371-2399.
27. von Kugelgen I., Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedebergs Archives of Pharmacology 2000, 362:310-323.
28. Von Kügelgen I. Pharmacology of mammalian P2X- and P2Y-receptors. Biotrend Reviews 2008, 3:1-11.
29. Messens J., Martins J.C., Van Belle K., et al. All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascade. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8506-8511.
30. Feng C., Mery A.G., Beller E.M., Favot C., Boyce J.A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. Journal of Immunology 2004, 173:7539-7547.
31. 2+-dependent ATP release from A549 cells involves synergistic autocrine stimulation by coreleased uridine nucleotides. Journal of Physiology 2007, 584:419-435.
32. 2+ ATPase (SERCA) inhibition. Journal of Bioenergetics and Biomembranes 2005, 37:365-368.
33. Ando H., Mizutani A., Matsu-ura T., Mikoshiba K. IRBIT, a novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor. Journal of Biological Chemistry 2003, 278:10602-10612.
34. Ando H., Mizutani A., Kiefer H., Tsuzurugi D., Michikawa T., Mikoshiba K. IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor. Molecular Cell 2006, 22:795-806.
35. Guerrero-Hernandez A., Gomez-Viquez L., Guerrero-Serna G., Rueda A. Ryanodine receptors in smooth muscle. Frontiers in Bioscience: A Journal and Virtual Library 2002, 7:d1676-d1688.
36. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nature Reviews Molecular Cell Biology 2000, 1:11-21.
37. Denda S., Kumamoto J., Takei K., Tsutsumi M., Aoki H., Denda M. Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis. Journal of Investigative Dermatology 2012, 132:69-75.
38. Yang K.L., Chang W.T., Chuang C.C., Hung K.C., Li E.I. Antagonizing TGF-beta induced liver fibrosis by a retinoic acid derivative through regulation of ROS and calcium influx. Biochemical and Biophysical Research Communications 2008, 365:484-489.
39. Yang L.H., Bai G.R., Huang X.Y., Sun F.Z. ERK binds, phosphorylates InsP3 type 1 receptor and regulates intracellular calcium dynamics in DT40 cells. Biochemical and Biophysical Research Communications 2006, 349:1339-1344.
40. (2)+ signaling in human airway epithelial cell wound response. Toxicological Sciences 2011, 121:191-206.